Literature DB >> 12884917

Regulators of G1 cyclin-dependent kinases and cancers.

Mong-Hong Lee1, Heng-Yin Yang.   

Abstract

The mammalian cell cycle can be divided into four phases: G1 (gap phase 1), S (DNA synthesis), G2 (gap phase 2), and M (mitosis). Progression through each phase of the cell cycle is delicately controled by the activity of different cyclin-dependent kinases (CDKs) and their regulatory subunits known as cyclins. CDK2, CDK4, CDK6 and their associated cyclins control the G1 to S phase transition. The association of CDK4 or CDK6 with D-type cyclins is critical for G1 phase progression, whereas the CDK2-cyclin E complex is important for initiation of the S phase. Cancer can originate from dysregulation of these regulators. A variety of intrinsic and extrinsic signals were recently identified to regulate these G1 or G1/S CDKs and cyclins. Here we discuss the regulators of these protein kinases at different mechanistic level with a hope that these insights can be applied to develop therapeutic strategies for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884917     DOI: 10.1023/a:1023785332315

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  46 in total

1.  BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro.

Authors:  Jin Bai; Peng-Jin Mei; Hui Liu; Chen Li; Wang Li; Yong-Ping Wu; Zheng-Quan Yu; Jun-Nian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-24       Impact factor: 4.553

2.  New roles for cyclin E in megakaryocytic polyploidization.

Authors:  Alexia Eliades; Nikolaos Papadantonakis; Katya Ravid
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

3.  Genome-wide annotation and expression profiling of cell cycle regulatory genes in Chlamydomonas reinhardtii.

Authors:  Katerina Bisova; Dmitri M Krylov; James G Umen
Journal:  Plant Physiol       Date:  2005-02       Impact factor: 8.340

4.  Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.

Authors:  A Villavicencio; A Goyeneche; C Telleria; K Bacallao; F Gabler; A Fuentes; M Vega
Journal:  Gynecol Oncol       Date:  2009-07-23       Impact factor: 5.482

Review 5.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

6.  The roles of microRNAs in tumorigenesis and angiogenesis.

Authors:  Weining Yang; Daniel Y Lee; Yaacov Ben-David
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-06-18

7.  CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.

Authors:  Wei Mo; Jian Chen; Amish Patel; Liang Zhang; Vincent Chau; Yanjiao Li; Woosung Cho; Kyun Lim; Jing Xu; Alexander J Lazar; Chad J Creighton; Svetlana Bolshakov; Renée M McKay; Dina Lev; Lu Q Le; Luis F Parada
Journal:  Cell       Date:  2013-02-21       Impact factor: 41.582

8.  NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.

Authors:  Alexander Köenig; Thomas Linhart; Katrin Schlengemann; Kristina Reutlinger; Jessica Wegele; Guido Adler; Garima Singh; Leonie Hofmann; Steffen Kunsch; Thomas Büch; Eva Schäfer; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Gastroenterology       Date:  2009-11-06       Impact factor: 22.682

9.  CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity.

Authors:  Ruiying Zhao; Heng-Yin Yang; Jihyun Shin; Liem Phan; Lekun Fang; Ting-Fang Che; Chun-Hui Su; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2013-02-19       Impact factor: 4.534

10.  MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.

Authors:  Li Hong; Liu Ya-Wei; Wang Hai; Zhou Qiang; Li Jun-Jie; Annie Huang; Qi Song-Tao; Lu Yun-Tao
Journal:  J Neurooncol       Date:  2016-03-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.